Healthcare Sales & Marketing Network News: preterm birth

Searching News Database: preterm birth

HSMN NewsFeed - 13 Feb 2025
Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Raliable Way to Predict the Risk of Developing Severe Preeclampsia
Diagnostics FDA

HSMN NewsFeed - 31 Oct 2024
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO(R) in South Korea
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics

HSMN NewsFeed - 30 Aug 2021
Visby Medical(TM) Receives FDA Clearance and CLIA Waiver at the Point of Care for PCR Sexual Health Test
Diagnostics FDA

HSMN NewsFeed - 14 Jun 2021
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Aug 2020
Lupin Presents Phase 3 Data for Solosec(R) (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Biopharmaceuticals

HSMN NewsFeed - 24 Feb 2020
Lipocine Announces Regulatory Path Forward for TLANDO(TM) Resubmission
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Nov 2019
Lipocine Receives Complete Response Letter for TLANDO(TM) from U.S. FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Aug 2019
Lipocine Announces Trial Date in Lipocine's Infringement Lawsuit Against Clarus Therapeutics and Will Seek a Permanent Injunction
Biopharmaceuticals Litigation

HSMN NewsFeed - 23 Jul 2019
Lipocine Receives FDA Clearance for Clinical Testing its NASH Candidate, LPCN 1144, in Expanded Target Population
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Apr 2019
FDA Grants Breakthrough Device Designation For Advanced Prenatal Therapeutics' Targeted Apheresis Column For Preeclampsia
Devices FDA

HSMN NewsFeed - 14 Feb 2019
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2 Study of LPCN 1144 in Biopsy Confirmed NASH Subjects
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Jan 2019
Slayback Pharma Announces FDA Approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml in a Multi-Dose Vial, the First Generic Equivalent of Makena(R) Injection 1,250 mg/ 5 ml Multi-Dose Vial
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 31 Aug 2018
Amneal Announces Partnership with American Regent on Generic Makena(R) and Progress on its Business Plan with Additional ANDA Approvals and Launches
Biopharmaceuticals Generics Distribution Product Launch

HSMN NewsFeed - 21 Jun 2018
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
Diagnostics OB/GYN Personnel

HSMN NewsFeed - 25 Apr 2018
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Biopharmaceutical Drug Delivery Licensing

HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 17 Apr 2017
AMAG Submits Supplemental New Drug Application to FDA for Makena(R) (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
Biopharmaceuticals Devices Drug Delivery FDA

HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Feb 2017
Lipocine Announces the Promotion of Gregory Bass to Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals

HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 17 Jul 2012
Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 17 Jun 2011
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Biopharmaceuticals Generics

HSMN NewsFeed - 10 May 2011
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology

HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 4 Jan 2011
Sera Prognostics Closes $1.4 Million Series A-1 Financing
Diagnostics Venture Capital

HSMN NewsFeed - 6 Dec 2010
PROCHIEVE 8% Vaginal Progesterone Gel Achieves Primary Endpoint in Phase III Study to Reduce Risk of Preterm Birth
Biopharmaceuticals

HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA

HSMN NewsFeed - 20 Oct 2010
K-V Pharmaceutical Company Announces Establishment of New Generic Marketing Subsidiary and Senior Executive Appointment
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 25 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA

HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices

HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory

HSMN NewsFeed - 1 Sep 2009
FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer
Devices Oncology FDA

HSMN NewsFeed - 13 Mar 2009
FDA Approves Two Hologic HPV Tests
Diagnostics FDA

HSMN NewsFeed - 9 Jun 2008
Hologic to Acquire Third Wave Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 22 Jan 2008
Hologic Announces Sale of Gestiva(TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Jan 2008
KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Oct 2007
Hologic and Cytyc Complete Merger
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 18 Oct 2007
Cytyc Stockholders Approve Hologic Merger
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 4 Oct 2007
Cytyc Ships Cellient(TM) Automated Cell Block Systems
Diagnostics

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Sep 2007
Cytyc Sets Special Meeting of Stockholders to Vote on Proposed Merger with Hologic, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 3 Jul 2007
Hologic and Cytyc Announce Expiration of Hart-Scott-Rodino Waiting Period
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 May 2007
Prolacta Bioscience Closes on over $12 Million in Private Funding
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 7 May 2007
Five-Year Results of Cytyc's MammoSite(R) Radiation Therapy System Presented at ASBS Annual Meeting
Devices Oncology

HSMN NewsFeed - 3 Apr 2007
Cytyc Acquires Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 12 Feb 2007
Cytyc to Acquire Adeza Biomedical Corporation
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 4 Feb 2007
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Biopharmaceuticals

HSMN NewsFeed - 31 Jan 2007
Adeza Receives Orphan Drug Designation for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2006
James Meer Appointed Chief Financial Officer of Columbia Laboratories
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2006
Adeza Receives FDA Approvable Letter for Gestiva
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jul 2006
FDA Accepts Adeza NDA Filing for Gestiva to Prevent Preterm Births
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
preterm birth
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.